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Differentiation of Neuronal Precursors
and Identifies Unique Patterns of
Down-stream Gene Expression
J. Matthew Velkey1,2 and K. Sue O’Shea1*
Background: Delineating the cascades of growth and transcription factor expression that shape the devel-
oping nervous system will improve our understanding of its molecular histogenesis and suggest strategies
for cell replacement therapies. In the current investigation, we examined the ability of the proneural
gene, Neurogenin1 (Neurog1; also Ngn1, Neurod3), to drive differentiation of pluripotent embryonic stem
cells (ESC). Results: Transient expression of Neurog1 in ESC was sufficient to initiate neuronal differen-
tiation, and produced neuronal subtypes reflecting its expression pattern in vivo. To begin to address the
molecular mechanisms involved, we used microarray analysis to identify potential down-stream targets
of Neurog1 expressed at sequential stages of neuronal differentiation. Conclusions: ESC expressing Neu-
rogenin1 begin to withdraw from cycle and form precursors that differentiate exclusively into neurons.
This work identifies unique patterns of gene expression following expression of Neurog1, including genes
and signaling pathways involved in process outgrowth and cell migration, regional differentiation of the
nervous system, and cell cycle. Developmental Dynamics 242:230–253, 2013. VC 2013 Wiley Periodicals, Inc.
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Key Findings:
 Inducible expression of Neurogenin1 in ESC provides a novel model of neurogenesis.
 Pulsed expression of Neurogenin1 produces PNS and CNS neuronal sub-types.
 Neurog1 promotes differentiation of neuronal precursors that exclusively form neurons.
 This is the first description of the gene expression cascade downstream of Neurog1.
Accepted 16 November 2012
INTRODUCTION
Vertebrate neurogenesis is a stepwise
process in which the primitive ecto-
derm is first induced to form the neu-
ral ectoderm, which folds forming the
neural tube. The neural tube is then
patterned along the anterior–poste-
rior (AP) and dorsal–ventral (DV)
axes by morphogens that coordinate
the expression of transcription factors
that confer positional identity and/or
promote neural differentiation. Pro-
neural basic helix–loop–helix (bHLH)
proteins comprise one such class of
transcription factor essential during
early neurogenesis (review, Bertrand
et al., 2002). In Drosophila, the bHLH
factors achaete-scute and atonal act
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as generic promoters of neuronal
differentiation and neuronal subtype
specification (Chien et al., 1996;
Jarman and Ahmed, 1998). Verte-
brate atonal homologs such as Neuro-
genin 1 (Neurog1), Neurogenin 2
(Neurog2; Gradwohl et al., 1996; Ma
et al., 1996; Sommer et al., 1996) and
achaete-scute homologs such as Atoh1
(Mash1; Johnson et al., 1990) and
Ascl1 (Math1; Guillemot and Joyner,
1993) also promote neuronal differen-
tiation both in vivo (Turner and
Weintraub, 1994; Lee et al., 1995;
Ma et al., 1996; Chung et al., 2002;
Kim et al., 2004) and in vitro
(Lo et al., 1998; Farah et al., 2000;
Sun et al., 2001; Kanda et al., 2004;
Satoh et al., 2010).
The expression of mammalian
achaete-scute and atonal homologues
within specific—largely nonoverlap-
ping—regions of the developing cen-
tral and peripheral nervous system
(CNS and PNS) suggests roles in neu-
ronal subtype specification that have
been confirmed by loss- and gain-of-
function studies. For example, Neu-
rog1 is expressed in the dorsal telece-
phalon where it appears to promote
glutaminergic neuronal fates, Atoh1
is expressed in the ventral telenceph-
alon specifying g-aminobutyric acid
(GABA)ergic neurons (Fode et al.,
2000; Parras et al., 2002; Kim et al.,
2011), while Neurog1 is expressed in
the caudal ventricular zone of the
rhombic lip, where it defines multiple
GABAergic lineages (Dalgard et al.,
2011). In the spinal cord, Ascl1 is
expressed in a dorsal stripe near
the roof plate (Gowan et al., 2001),
Neurog1 is expressed in the ventral
half and in a small region just below
the roof plate, whereas Atoh1 is found
in the intervening domain (Sommer
et al., 1996; Ma et al., 1997), where
these transcription factors are
thought to regulate neuronal pheno-
type by cross-inhibition (Briscoe
et al., 2000; Gowan et al., 2001;
Helms et al., 2005). Loss-of-function
studies have shown that Neurog1 is
required for the development of dI2
dorsal spinal neurons, trigeminal and
otic cranial sensory ganglia, and TrkA
neurons of dorsal root ganglia (DRG)
(Ma et al., 1997; Fode et al., 1998;
Gowan et al., 2001). Gain-of-function
studies have demonstrated that over-
expression of Neurog1 biases the
migration of neural crest stem cells
toward dorsal root sensory ganglia in
vivo (Perez et al., 1999), whereas
forced expression of Neurog1 in dorsal
neural tube progenitors and neural
crest cells promotes their differentia-
tion into sensory lineages (Lo et al.,
2002). These data indicate that Neu-
rog1 is required for the development
of sensory neuronal lineages in both
the PNS and CNS; however, it is not
clear whether Neurog1 is itself suffi-
cient to induce these lineages because
the gain-of-function studies were con-
ducted either in the embryo or in neu-
ral progenitors where the effects of
morphogens and other instructive sig-
nals cannot be separated. While mis-
expression of proneural genes can
produce ectopic neurogenesis in a va-
riety of species (Quan and Hassan,
2005), relatively little is known
regarding the molecular mechanisms
involved or down-stream gene expres-
sion following bHLH gene expression.
Because bHLH transcription factor
expression is strongly affected by spa-
tial and temporal context (Powell and
Jarman, 2008), we used a gain-of-
function approach in pluripotent em-
bryonic stem cells (ESC) to determine
the role of Neurog1 in cell fate specifi-
cation. ESC may be a particularly in-
formative starting material because
they have a bivalent chromatin struc-
ture with promoters poised for both
lineage differentiation as well as for
self-renewal (e.g., Boyer et al., 2006).
Lineage specifying genes such as
bHLH and paired-box family mem-
bers may therefore control differen-
tiation programs by directly affecting
transcription and by narrowing differ-
entiation choices by controlling
chromatin.
The current investigation identifies
potential down-stream targets of Neu-
rog1 including genes involved in cell
cycle, cell migration and process out-
growth, and provides a source of neu-
ronal precursor cells that remain
sensitive to patterning molecules.
Consistent with observations that
Neurog1 is present in cells about to
withdraw from cycle and differentiate
into layer-specific neurons (Kim et al.,
2011), forced expression of Neurog1 in
ESC alters their cell cycle characteris-
tics and is sufficient to initiate neuro-
nal differentiation in the absence of
other inducing factors. In fact, Neu-
rog1 expression was sufficient to over-
come the inhibitory effects of LIF and
serum proteins on ESC differentiation
(Williams et al., 1988). In addition,
Neurog1 expression was also suffi-
cient to generate both CNS and PNS
neuronal subtypes typical of those de-
pendent on Neurog1 in vivo. Yet, the
positional identity and neuronal dif-
ferentiation potential of induced cells
could be influenced by early acting
patterning factors, suggesting that
Neurog1 promotes differentiation of
neuronal precursors that can be influ-
enced by the local microenvironment





In the current investigation, we used
the Ainv15 ESC line (Kyba et al.,
2002) that expresses a “Tet-on”
reverse tetracycline transactivator
(rtTA) from the constitutively active
ROSA26 locus, and a tet-inducible
element with a LoxP targeting site
and a truncated neomycin resistance
cassette placed upstream of the
HPRT locus. Site-specific integration
of the targeting vector carrying cDNA
for a gene of interest places the trans-
gene downstream of the tet-inducible
element and confers neomycin resist-
ance, thereby allowing efficient selec-
tion of targeted cell lines. Once
selected, cells are maintained in neo-
mycin to ensure that the transgene
does not undergo methylation or rear-
rangement, although this is unlikely
at the HPRT locus (Wutz et al., 2002).
We targeted Neurog1 to the induci-
ble locus and obtained several G418
resistant colonies which were
expanded to cell lines. Based on the
reliability of this inducible system
(Kyba et al., 2002; M. Kyba and G.
Keller, personal communication) and
our own analyses in which we
observed no differences between the
ESC lines in their differentiation
capacity or response to the tetracy-
cline analog doxycycline (data not
shown), one line (N7) was selected for
most subsequent experiments. As
indicated in Figure 1A, robust Neu-
rog1 expression in N7 cells was
induced within 12 hr of addition of
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doxycycline (dox), to monolayer cul-
tures grown in either complete ES
medium, which inhibits spontaneous
differentiation (Williams et al., 1988)
or in a defined neural medium, which
supports neural differentiation of
ESC in monolayer cultures. We did
not observe any evidence of transgene
silencing as Neurog1 expression was
maintained throughout the culture
period. N7 cells cultured in complete
(ES) medium without dox did not
express Neurog1 at 12, 24, 48, or 72
hr (Fig. 1A). N7 cells cultured in
defined neural medium without dox
were intolerant of these culture condi-
tions often undergoing cell death by
72 hr (not shown). However, in cells
that survived to 72 hr, it was possible
to detect slight expression of Neurog1
(Fig. 1A), likely due to stochastic neu-
ral differentiation and activation of
endogenous Neurog1 elicited by cul-
ture in these conditions. When cul-
tured in a different serum-free
medium containing 5% knock-out se-
rum replacer (Fig. 1B), we observed
no expression of Neurog1 in the ab-
sence of dox, but, in the dox-treated
groups, we could consistently induce
expression of the Neurog1 transgene
in a dose-dependent manner. Overall,
these data suggest that the N7 cell
line provides a consistent and tightly
regulatable means to assess the
sequelae of Neurog1 expression in
ESC.
Expression of Neurog1 in ESC
Induces Neuronal
Differentiation
Within 24 hr of inducing the Neurog1
transgene, N7 cells exhibited overt
neuronal morphologies including
round, phase-bright somata and one
or more long cytoplasmic processes
when viewed with phase contrast mi-
croscopy. Cells cultured in complete
(ES) medium or in defined neural me-
dium (DM) with dox were fixed after
12, 24, 48, and 72 hr in culture fol-
lowed by immunohistochemical local-
ization of Neurog1 and neuronal
tubulin (TuJ1 antibody). Virtually all
of the cells cultured in the presence of
dox were Neurog1þ at each time point
surveyed (Fig. 2), whereas those cul-
tured without dox were largely Neu-
rog1 (not shown), confirming the
integrity of the tet-inducible locus.
TuJ1 immunostaining demonstrated
weakly reactive cells in both culture
conditions as early as 12 hr following
transgene induction, indicating the
initiation of neuronal differentiation
(Fig. 2A,B,I,J), although in defined
medium there were occasionally cells
that exhibited a more mature neuro-
nal phenotype (Fig. 2A,B). In general,
neuronal differentiation was robust in
either culture condition after 72 hr of
transgene induction, but differentia-
tion progressed more rapidly in
defined medium. After 72 hr, cell den-
sity was also considerably greater in
cultures grown in complete medium.
Overall, forced expression of Neurog1




G1 Phase of the Cell Cycle
Neurog1 has previously been reported
to promote cell cycle exit (Farah et al.,
2000), to increase G1/G0 and decrease
S phase (Piao et al., 2012), but the
kinetics and target genes are not
known. To examine this directly, we
first determined the growth charac-
teristics of control Ainv15 and N7
cells in the presence and absence of
doxycycline at 24-hr intervals. There
was no significant difference in cell
number between control Ainv15 ESC
exposed to doxycycline and N7 cells
grown without dox at any time point
(Fig. 3A). Although there was no sig-
nificant change in cell number at 24
hr of culture, by 48 and 72 hr of trans-
gene induction, there was a signifi-
cant decrease in the number of
Neurog1-expressing N7 cells com-
pared with uninduced N7 or control
Ainv15 ESC (P0.001, Student’s t-
test).
To determine where in the cell cycle
Neurog1 expression affects prolifera-
tion, we cultured control Ainv15 and
N7 cells6dox for 72 hr, labeled the
cells with propidium iodide and used
fluorescence activated cell sorting
(FACS) to analyze cell cycle character-
istics. Consistent with the prolifera-
tion data, there was little difference
in the cycle characteristics of control
Ainv15 ESC grown in the presence of
doxycycline and N7 cells grown with-
out dox: 36.8 and 38.1% of the cells
were in G1, 50.8 and 50% in S, and
12.4 vs. 11.9% in G2/M in con-
trolþdox, and N7dox cells, respec-
tively (Fig. 3B). Induction of Neurog1
expression had a significant effect on
the number of cells in G1 phase; with
66.2% in G1, 22.9% in S, and 10.9% in
G2/M. Cell death was similar in N7
ESC exposed to doxycycline
(8.862.7%) and N7 not exposed to dox
(8.260.5%), but only 4.060.8% in con-
trol Ainv15 ESC grown with doxycy-
cline. These data demonstrate that
induction of Neurog1 expression in
Fig. 1. Characterization of dox-inducible Neurog1 embryonic stem cells (ESC). A: Cells cul-
tured in either complete ES medium or in defined neural medium with 1 mg/ml doxycycline
express Neurog1 by reverse transcriptase-polymerase chain reaction (RT-PCR) within 12 hr of
treatment, which was maintained 72 hr in culture. Cells cultured in defined neural medium with-
out the addition of dox showed a very slight up-regulation of Neurog1 after 72 hr. Controls
include pooled cDNA from day 9–11 mouse embryos (d9–11) and N7 cells cultured in ES me-
dium without dox (0 hr). B: N7 cells grown in serum free minimal medium (DMEM with 5%
knockout serum replacement) with 0, 0.5, 1, or 2 mg/ml doxycycline express Neurog1 in a dose-
dependent manner. After 72 hr, cells not exposed to doxycycline show no expression of
Neurog1.
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ES cells slows proliferation by signifi-
cantly increasing G1 and decreasing
the proportion of cells in the S phase




To determine the anterior–posterior
characteristics of the differentiating
cells, and to determine their respon-
siveness to patterning factors, cells
were grown in defined neural medium
with and without 1 mm retinoic acid
(RA). Expression of Otx2, a forebrain
marker (Mallamaci et al., 1996), and
Hoxc6, expressed in the rostral cervi-
cal spinal cord, were examined. In
both culture media, cells expressed
Otx2 but not Hoxc6 at all time points
assayed, indicative of a forebrain phe-
notype (Fig. 4A). When N7 cells were
cultured for 3 days in defined medium
supplemented with 1 mM RA and dox,
there was a significant reduction in
Otx2 expression and concomitant
up-regulation of Hoxc6 (Fig. 4A). Like
previous studies of ESC (Wichterle
et al., 2002), these findings suggest
that N7 cells neuralized by forced
Neurog1 expression have an initial
anterior (forebrain) phenotype that
can be posteriorized by exposure to RA.
Expression of Dorsal and
Ventral Markers Reflects
Neurog1 Expression In Vivo
Molecular markers of dorsal–ventral
identity in the posterior neural
tube have been well-characterized
(reviewed in Jessell, 2000; Helms
and Johnson, 2003; Helms et al.,
2005; Fig. 4B); Neurog1 is expressed
in the ventral half and near the roof
plate of the developing posterior neu-
ral tube (Sommer et al., 1996; Ma
et al., 1997, Fig. 4B). We therefore
sought to determine if induction of
the Neurog1 transgene could produce
a similarly mixed population of
Fig. 2. Expression of Neurog1 induces widespread neuronal differentiation of embryonic stem cells (ESC). A–P: Cells were cultured in defined
neural medium (A–H) or in complete ES maintenance medium (I–P) supplemented with 1 mg/ml doxycycline. A,I: In both media, as early as 12 hr
after dox induction, ESC expressed Neurog1 (green). B,J: Expression of neuronal tubulin (TuJ1, red) illustrates the initiation of neuronal differentia-
tion within 12 hr of dox treatment in both culture conditions. M,N: Cells grown in defined neural medium demonstrate overt neuronal differentiation
(evidenced by neurite extension) as early as 12 hr after treatment whereas cells cultured in ES Medium do not exhibit morphological characteris-
tics of mature neurons until 48 hr of treatment with doxycycline. C,D,K,L: These differences were maintained at 48 hr. By 72 hr, neuronal differen-
tiation was extensive in both culture conditions. G,H,O,P: Cells grown in defined neural medium were highly enriched in neurons (G,H), whereas
cultures grown in complete medium show the persistence of non-neuronal cells (O,P). Scale bar¼100 mm.
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dorsal and ventral subtypes following
treatment with retinoic acid. We
examined induced cell cultures
grown in ESC medium, in which an
indeterminate amount of RA was
likely present in the fetal bovine se-
rum constituent (Napoli, 1986), and
in defined neural medium supple-
mented with 1 mM RA. When assayed
by reverse transcriptase-polymerase
chain reaction (RT-PCR), induced
cultures expressed markers associ-
ated with the dorsal (Pax3, Pax7),
ventral (Nkx2.2, Nkx6.1), and middle
(Dbx2) thirds of the developing neu-
ral tube (Fig. 4C), which generally
correspond to regions of Neurog1
expression in vivo. Differences in the
timing of expression were observed
between the proteins assayed; e.g.,
Dbx2 expression was evident within
12 hr of inducing the Neurog1 trans-
gene, although it was not expressed
by undifferentiated ESC, while ro-
bust Pax7 expression was not
observed until 48 hr after induction.
Of interest, in subsequent experi-
ments, Pax7 and Nkx6.1 were rarely
co-expressed (Fig. 7), indicating the
presence of distinct dorsal and ven-
tral subtypes. Thus, forced expres-
sion of Neurog1 in ESC produces a
population of precursors that approx-
imately recapitulates the in vivo pat-
tern of Neurog1 expression.
Forced Expression of
Neurog1 Produces CNS and
PNS Neurons
The distribution of CNS and PNS
phenotypes was determined after 5
days of culture with and without the
addition of RA. Cells were grown in
defined medium plus dox to induce
the Neurog1 transgene for 72 hr then
switched to a medium supplemented
with 5% knockout serum replacer
(SRM5) without dox for 48 hr, as
these conditions increased cell sur-
vival. After 5 days, there was exten-
sive neuronal differentiation as
evidenced by TuJ1 immunoreactivity
(Fig. 5A); a subset of these cells (Fig.
5B) was also positive for peripherin,
with a Tuj1þ:peripherinþ ratio of
approximately 21:1 (Table 1). To
obtain quantitative data, we scored
only peripherinþ somata, so these
data likely underestimate the total,
as there were many peripherinþ
fibers whose cell bodies were outside
the field of view. Some neurons
expressed Islet1 (Fig. 5C), and, invar-
iably, these cells were also Brn3aþ
(Fig. 5D), an expression pattern typi-
cal of sensory ganglia (SG) of the PNS
as well as of dI3 dorsal interneurons
in the CNS (Gowan et al., 2001).
There were also many Brn3aþ/Isl1
cells (Fig. 5C,D); an expression pat-
tern that characterizes dI-1, 2, or 5
interneurons in the CNS (reviewed in
Helms and Johnson, 2003). Nearly all
(approximately 97%) of the periph-
erinþ cells were also Brn3aþ and had
long, well-developed processes and
unipolar or bipolar morphologies (Fig.
5E,F)—a pattern most consistent
with a SG neuronal phenotype. Of in-
terest, there was little statistically
significant difference in marker
expression in groups exposed to RA
vs. those not exposed to RA, although
the overall number of neurons pres-
ent as evidenced by TuJ1 immunore-
activity was slightly higher in the RA-
treated cultures as was the number of
peripherinþ neurons (Table 1).
Induced Cells Respond to
Dorsal–Ventral Patterning
Factors
Because forced expression of Neurog1
in ESC is sufficient to promote both
dorsal and ventral neural phenotypes,
we wished to determine if the result-
ing neuronal cells could be patterned
by exogenous factors. We cultured N7
cells in defined medium with dox and
RA for the first 3 days and then
changed the culture media to a serum
replacement medium (SRM) with RA
but not dox, to enhance cell survival.
To test the effects of exogenous fac-
tors, media were supplemented with
Sonic hedgehog (Shh), bone morpho-
genetic protein-4 (BMP4), or Noggin
(Nog) recombinant proteins from the
beginning of each experiment. RT-
PCR analysis indicated that Shh
Fig. 3. Expression of Neurogenin1 decreases proliferation and alters cell cycle characteris-
tics. A: At 24 hr, there was no significant effect of transgene expression on cell number, but at
48 and 72 hr there were significantly fewer N7 cells grown with Dox, compared with either N7
cells alone (N7Dox), or control Ainv15 cells with Dox (CþDox). Means represent cell number
from four biological replicates, 12 wells each. *P0.001, Students t-test. B: N7 (N7Dox) and
control Ainv15 (ControlþDox) cells were grown for 72 hr6Doxycycline, then subjected to cell
cycle analysis. Induction of Neurog1 expression (N7þDox) significantly increased G1
and decreased S phase compared with cells absent transgene induction. *P0.001, Student’s
t-test.
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treatment induced expression of the
ventral marker, Nkx6.1, and sup-
pressed expression of the dorsal
marker, Pax7 (Fig. 6A). Exposure of
cells to either high (25 nM) or low (2.5
nM) concentrations of Shh, resulted
in a dose-dependent expression of
ventral markers. On day 1, cultures
grown in either high or low levels of
Shh expressed higher levels of Nkx6.1
compared with those without Shh. At
day 3, Nkx6.1 expression levels were
similar between Shh-treated and
untreated cultures, but by day 5, cells
grown in the high Shh condition
expressed higher levels of Nkx6.1.
Expression of the intermediate dor-
sal–ventral marker, Dbx2, was
reduced by treatment with Shh in a
dose-dependent manner. Treatment
with Shh also resulted in the expres-
sion of Islet1, which is associated with
motor neurons in the ventral spinal
cord, and of nestin, expressed by neu-
ral ectoderm and neural stem cells.
Treatment with BMP4 (5 nM) dras-
tically reduced CNS neural differen-
tiation as evidenced by down-
regulation of all three CNS neural
progenitor markers (Pax7, Dbx2, and
Nkx6.1) (Fig. 6A). RT-PCR analysis
confirmed expression in BMP4
exposed cultures of GATA-4, Bra-
chyury, and Claudin6, markers of
endoderm, mesoderm, and epidermal
ectoderm respectively (not shown).
BMP4-treated cultures also showed a
marked increase in the expression of
Snail, a marker of EMT and early
neural crest cells and of peripherin,
expressed in the PNS and motor neu-
rons (Fig. 6A), although we did not
observe many overtly neuronal cells
in these cultures. Taken together,
these data support the recognized role
of BMPs as neural antagonists in the
early gastrula stage embryo as well
as during the early stages of mouse
ESC differentiation. However, the
expression of neural crest and PNS
markers suggests that, in the context
of forced Neurog1 expression, BMPs
can act instructively to promote neu-
ral crest and PNS phenotypes (e.g.,
Aihara et al., 2010).
To address the possibility that en-
dogenous BMPs might influence the
neuronal differentiation observed in
our cultures, we treated cell cultures
with low (2 nM) or high (5 nM) levels
of the BMP antagonist, Noggin (Nog),
in combination with low or high Shh
treatment. Consistent with previous
observations, Shh-treated cultures
expressed low levels of the dorsal
marker, Pax7 (Fig. 6B). Of interest,
Pax7 expression in Nog-treated cul-
tures was higher than untreated con-
trols. However, as we observed that
Nog treatment appeared to enhance
neuronal differentiation and/or sur-
vival such that there were many more
neurons and primitive neural
Fig. 4. Expression of dorsal and ventral markers reflects Neurog1 expression in vivo. A: Cells
induced in the absence of retinoic acid (RA) demonstrate an anterior neural phenotype (expres-
sion of Otx2), whereas a marker of spinal cord (Hoxc6) was not expressed. Cells treated with 1
mM RA show diminished Otx2 expression and increased expression of Hoxc6 indicating that the
anterior–posterior identity of the neuronal precursors can be modulated by treatment with RA.
B: Neurog1 is expressed in the ventral half of the developing neural tube, in the roof plate and
neural crest-associated structures such as dorsal root ganglia. Pax3 and Pax7 are expressed in
the dorsal half of the cord, Dbx2 in the middle third, Nkx6.1 and Nkx2.2 in the ventral spinal
cord. C: With differentiation in either complete ES medium (in which some RA is likely present in
the serum), or in defined neural medium supplemented with 1 mM RA, expression of dorsal
(Pax3 and Pax7), intermediate (Dbx2), and ventral (Nkx2.2 and 6.1) markers were observed in
RT-PCR.
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Fig. 5. Induced N7 cells form central nervous system (CNS) and peripheral nervous system (PNS) phenotypes. N7 cells were grown for three
days in defined neural medium in the presence of Dox, followed by two days without Dox61 mM RA. A,B: N7 cultures grown with RA for 5 days
exhibit widespread neurogenesis. Some TuJ1þ neurons were also Periþ. Similar results were observed in RA-free cultures (not shown), although
there was a slight attenuation in the overall number of neurons observed (see text and Table 1). C,D: Cells cultured in defined medium with RA for
5 days illustrating the presence of Isl1þ and Brn3aþ neurons. Isl1þ/Brn3aþ are co-expressed in dorsal interneurons (lamina 3), and in sensory
ganglia; Isl1-Brn3aþ expression is typical of dI- 1, 2, or 5 in CNS (dI-2 precursors are normally Neurog1þ); Isl1þ/Brn3a- expression is typical of
CNS motor neurons. Most Isl1þ cells were Brn3aþ, but not all Brn3aþ cells were Isl1þ. E,F: Cells cultured þRA (E) or RA (F) for 5 days illustrat-
ing Periþ/Brn3aþ (SG phenotype) cells. The overall frequency was similar in þRA and RA-treated cultures. Nearly all cells that were Periþ were
also Brn3aþ.
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“rosettes” present in Nog-treated
groups compared either with controls
or cultures treated with Shh alone
(not shown). Because the enhanced
Pax7 signal could be due to the
increase in neuronal differentiation,
we examined the expression of
Nkx6.1 and Pax7 using immunohisto-
chemistry (Fig. 7) after 5 days of
differentiation. Very few cells co-ex-
pressed Pax7 and Nkx6.1, indicating
that the cultures contained a mixed
population of precursor cells that
could be characterized as distinctly
"dorsal" (i.e., Pax7þ) or "ventral" (i.e.,
Nkx6.1þ). After quantifying the Pax7
and Nkx6.1-positive populations, we
then applied the Tuj1 antibody to
assess overall neuronal differentia-
tion and found little difference
between the treatment groups.
Moreover, the Tuj1þ neurons were
generally neither Pax7þ nor
Nkx6.1þ, further confirming that
these markers labeled precursors
rather than more mature neurons
(Fig. 7, right panel). In cultures not
treated with Shh or Nog, 46.1% (6
1.0) of cells were Pax7 positive, while
14.4% (6 0.4) were Nkx6.1 positive
(Fig. 8). Treatment with either Shh
or Nog at low or high levels resulted
in a significant reduction in Pax7 im-
munoreactivity and a corresponding
increase in the number of Nkx6.1-
positive cells. We also observed
more ventral phenotypes in Shh-
treated groups compared with Nog
treatment, and the ventralizing
effect appeared to be dose-depend-
ent. Of interest, co-application of
Shh and Nog at either dose pro-
duced more ventral phenotypes
than either factor alone, suggesting
that these two molecules may act
synergistically to promote ventral
phenotypes. Altogether, the data
suggest that forced expression of
Neurog1 in ESC produces a popula-
tion of neuronal precursors that
remain responsive to extrinsic pat-
terning signals.
Neural Induction by Means of
Forced Neurog1 Expression
Can Be Influenced by
Fibroblast Growth Factor
Signaling
The role of fibroblast growth factor
(Fgf) signaling in neural induction
and ESC differentiation is unre-
solved, with some studies suggesting
that Fgf signaling is indispensable in
neural induction both in vivo (Streit
et al., 2000) and in ESC in vitro (Ying
et al., 2003a). To assess the role of Fgf
signaling during neuronal differentia-
tion of ESC in the context of Neurog1
expression, we exposed N7 cells in
defined medium to a 12-hr pulse of 5
nM SU5402, which targets the kinase
domain of FGFR1 and therefore abro-
gates all signaling by this receptor
(Mohammadi et al., 1997). We treated
cells at three intervals: 12 hr before
the addition of dox (pre-dox), concur-
rent with the addition of dox (simulta-
neous), and 12 hr following the
addition of dox (post-dox); the control
group received dox 12 hr after plating
(Fig. 9A). Cells were then cultured for
72 hr in defined neural medium con-
taining dox then assayed for the
expression of Sox3, a marker of neu-
ral ectoderm and neuronal precur-
sors, TuJ1 labeling early neurons, or
Oct4, expressed in undifferentiated
ESC. Media changes and monitoring
by phase microscopy occurred at 12,
24, 36, and 48 hr at which time we
observed no differences in cell death
(as evidenced by nonadherent cells
observed in the plates and trypan
blue staining of withdrawn media)
across any of the treatment groups
compared with controls. Consistent
with either a requirement for Fgf/
ERK signaling for ESC differentiation
(Kunath et al., 2007), or alternatively,
that Fgf/ERK signaling prevents de-
differentiation to a more primitive
ES-like state (Greber et al., 2010),
there were considerably more Oct4-
expressing cells (53.465.4%) in the
pre-dox group (Fig. 9B). Neuronal dif-
ferentiation as evidenced by Tuj1 im-
munoreactivity was strikingly
reduced in the pre-dox group
(16.766.2%) and the number of
Sox3þ precursors (66.367.4%) was
higher compared with the other treat-
ment groups. Simultaneous inhibition
of Fgf signaling with Neurog1 induc-
tion resulted in many fewer Oct4þ
ESC (18.462.3%), and slightly more
TuJ1þ neurons (28.161.9%) com-
pared with the pre-dox group. The
number of Sox3þ precursors was
slightly reduced in the simultaneous
group (63.566.6%) compared with the
pre-dox group, but the difference only
approached statistical significance
(P¼0.06). In the post-dox group, very
few Oct4þ ESC remained (5.563.5%).
There was also a slight, but
TABLE 1. Distribution of Neuronal Markersa
TuJ1/Peripherin staining þRA RA þRA vs. –RA P¼
%TuJ1þ 69.261.2 63.761.5 <0.001
%Peripherinþ somata 3.560.3 2.960.2 0.022
TuJ1þ: Peripherinþ 20.961.6:1 22.761.3:1 0.143
Brn3a/Peripherin staining
%Peripherinþ somata 3.460.4 2.960.2 0.032
%Brn3aþ 17.861.0 16.161.0 0.063
% of Periþ also Brn3aþ 96.962.4 96.862.5 0.4755
Brn3a/Isl1 staining
%Brn3a (total) 18.160.9 16.761.1 0.067
Brn3aþ/Isl1þ 7.460.7 6.560.5 0.065
Brn3aþ/Isl1 11.360.8 10.361.2 0.168
%Isl1þ (total) 7.460.6 6.560.5 0.095
Isl1þ/Brn3a 0.260.1 0.160.1 0.191
aN7 cells were grown for three days in defined neural medium in the presence of
Dox, followed by two days without Dox in defined neural medium61 mM retinoic
acid (RA). At least 1000 cells from 10 randomly selected fields in three replicate
dishes were scored for immunoreactivity to the markers indicated and divided by
the total cell number in each field determined by Hoechst nuclear staining. The
data presented are the overall means for each treatment group6SEM across the
three replicates. P values are based on results of analysis of variance, followed by
pairwise Student’s t-test.
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statistically significant (P0.05),
reduction in the number of Sox3þ
precursors (58.863.9%) in the post-
dox group compared with either the
pre-dox or simultaneous treatment
groups, and a concomitant increase in
the number of mature neurons
(40.566.2%). Controls receiving no
SU5402 showed a dramatic overall
increase in differentiation as there
were few Oct4þ cells remaining
(0.761.0%), and a significant reduc-
tion in the number of Sox3þ precur-
sors (35.966.4%). The number of
TuJ1þ neurons in the control group
was much higher than any of the
treatment groups (64.664.7%), sug-
gesting that the reduction in Sox3þ
cell numbers was likely the result of
increased differentiation of the Sox3þ
precursor pool into (Tuj1þ/Sox3)
neurons. Overall, these data indicate
that the induction of Sox3þ neuronal
precursors in the context of Neurog1
expression is largely Fgf-independent,
but there is a temporal window within
which neuronal differentiation can be
held in check by Fgf-mediated persist-
ence of the Oct4 pluripotency
pathway.
Microarray Analysis
After 24 hr of transgene induction,
1,384 genes were significantly differ-
entially expressed; 951 up-regulated.
At 48 hr, 5,894 genes were signifi-
cantly altered (2,856 up-regulated);
increasing to 7,205 (3,263 up-regu-
lated) after 72 hr of doxycycline expo-
sure. Gene ontology classification
analysis identified significant altera-
tions in the expression of genes asso-
ciated with: nervous system
development (48%), development
(24%), metabolism (4%), cell cycle
(4%), signaling (4%), and cellular or-
ganization (4%). Supplementary Ta-
ble S1, which is available online,
summarizes the results of functional
annotation clustering of genes signifi-
cantly up- and down-regulated at 24,
48, and 72 hr of transgene induction.
There were significant changes in the
expression of genes involved in neuro-
genesis, in process outgrowth and cell
migration, those involved in the re-
gional development of the nervous
system, in cell cycle, as well as genes
involved in ESC homeostasis.
We carried out KEGG pathway
analysis to map alterations in signal-
ing pathways and molecular functions
and identified sequential induction of
genes in pathways involved in axon
guidance, cancer and melanogenesis
(Supp. Table S2). By 72 hr of trans-
gene induction, 19 pathways were
activated, including: ErbB, Neurotro-
phin, Wnt, Mapk, Focal adhesion,
Calcium, and Insulin signaling path-
ways. After 72 hr, only one pathway,
cysteine and methionine metabolism,
was significantly down-regulated.
Consistent with our RT-PCR
results, Neurog1 was up-regulated
74-, 74-, and 42.7-fold at 24-hr inter-
vals compared with uninduced cells.
Other bHLH genes were also induced:
Neurod4 increased by 33-, 206-, and
127.8-fold; Neurod1 increased 9.7-,
11.5-, and 10.2-fold, while Neurog2
was up-regulated by: 0-, 4.4-, and 3.8-
fold (Table 2). Pluripotency factors
expressed by undifferentiated ESC:
Eed, Eras, Fbxo15, Foxd3, Klf2, Klf4,
Nanog, Pou5f1 (Oct4), Sox2, Zic3,
were significantly down-regulated
with differentiation. Genes associated
with neurogenesis including: Ebf2,
Ebf3, Elavl3, Elavl4, Fabp7, Hes5,
Lhx2, Ncam1, Nhlh1, Nhlh4, Pax3,
Fig. 6. Induced N7 cells respond to patterning factors. N7 cells were cultured for 3 days in
defined neural medium with 1 mg/ml doxycycline (þ Dox) and then switched to serum replace-
ment (SR) medium without Dox for 2 additional days of culture. Media were supplemented with
1 mM retinoic acid (RA) and growth factors as indicated for the entire time in culture. Samples
from noninduced N7 cells grown in complete medium (ES) and pooled RNA from d9, 10, and 11
embryos (d9–11) show expected expression of all markers assayed. b-actin is included as a
positive control. #Shh¼2.5 nM, "Shh¼25 nM, "BMP¼5 nM BMP4, #Nog¼2 nM, "Nog¼5 nM. A:
Sonic hedgehog (Shh) and bone morphogenetic protein-4 (BMP4) treatment: Cells induced in
the presence of either low or high doses of Shh show reduced expression of both dorsal (Pax7)
and intermediate (Dbx2) neural tube markers and increased expression of a ventral marker
(Nkx6.1) compared with untreated cells. In Shh-treated cultures, down-regulation of Dbx2 and
up-regulation of Nkx6.1 and Islet1, were dose-dependent. Shh treatment also resulted in up-reg-
ulation of the neural stem cell-associated intermediate filament protein, Nestin, by d5 of culture.
BMP4-treated cultures show up-regulation of Snail, a marker of premigratory neural crest, and
Peripherin, a peripheral neuronal marker, and abrogation of all other neural markers assayed. B:
Shh and Noggin treatment: Cells were induced in the presence of combinations of Shh and a
BMP antagonist, Noggin (Nog). In general, all treatment groups showed increased expression of
Nkx6.1 compared with untreated cells. Expression of Pax7 increased in Nog-treated groups,
likely due to an overall increase in the number of neural progenitors as evidenced by increased
expression of Nestin. Cultures treated with high doses of Shh and Nog show no expression of
Pax7, indicating that these cultures are ventralized by Shh treatment. Shh-treated cells also
show increased expression of Islet1 and Peripherin, markers both present in ventral motor neu-
rons, and diminished expression of Snail. High doses of Nog also reduced expression of the in-
termediate neural tube marker Dbx2, suggesting a role for BMP signaling in establishing this
lineage.
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Fig. 7. Shift in dorsal–ventral phenotypes with Sonic hedgehog (Shh) and Noggin (Nog) treatment. Left panels: Immunostaining with Nkx6.1
(green nuclei) and Pax7 antibodies (red nuclei) indicate that more Pax7þ precursors are present in the absence of or at low doses of Shh and/or
Nog. Higher doses of Shh and/or Nog reduce the number of Pax7þ cells observed and generate more Nkx6.1þ cells (not shown), and the appli-
cation of high doses of Shh and Nog together ("Shh"Nog) resulted in a dramatic increase in Nkx6.1þ cells and a concomitant decrease in the
number of Pax7þ cells. Total cell number in each field was determined by Hoechst nuclear staining (blue). Scale bar¼100 micrometers. Right pan-
els: After cell counts, cultures were stained with Tuj1 to distinguish neurons (red cytoplasm), which are largely Pax7- (red nuclei) and Nkx6.1-
(green nuclei) as might be expected for markers that are normally down-regulated with differentiation. Scale bar¼50 micrometers.
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Pax6, Reln, Zic1, were induced, while
the negative regulator of neurogenesis
Rest (RE1-silencing factor), was down-
regulated. Many genes expressed in
the ventricular zone (Fu et al., 2009)
and by neural stem cells including
Dll1, Dcx, Prom1, Reln, Coup-TFI and
II (Naka et al., 2008), and Hes5 (Hata-
keyama et al., 2004; Basak and Taylor,
2007) were expressed, as were genes
associated with cell cycle exit and
differentiation including Ebf2,3
(Pozzoli et al., 2001; Garcia-Domi-
nguez et al., 2003). Id4, Pax3, Pax6,
Sox3, Sox4, and Sox11 (Bergsland
et al., 2006) were also increased. Fac-
tors involved in process outgrowth and
cell migration including ephrins and
their Eph receptors, semaphorins and
plexins, were induced by Neurog1. Of
interest, epithelial genes including
junctional proteins and cell–cell adhe-
sion molecules such as E-Cadherin
(Cdh1) were down-regulated whereas
N-Cadherin (Cdh2) expression signifi-
cantly increased.
There were also significant
increases in the expression of genes
associated with regional neuronal cell
types, including telencephalon-associ-
ated genes Elavl4, Fabp7, Foxd1 and
Foxg1. Lhx2, which plays a critical
role in cortical patterning (Mangale
et al., 2008; Chou et al., 2009) was
particularly strongly induced by Neu-
rogenin1. Several factors associated
with ventral neural fates, e.g., striatal
(Foxp2), midbrain (Pcdh8), and mid-
brain dopaminergic neurons (Foxa2,
Ebf3) were also induced. Hindbrain
markers Hoxa2 and Hoxb2 were sig-
nificantly induced, as was Hoxd9,
which is expressed in thoracic lateral
motor neuron columns (Dasen et al.,
2005). Other genes associated with a
motor neuron phenotype such as
Irex3 and Isl1 were also significantly
increased. Genes expressed in ce-
phalic placodes including Eya1, Ebf2,
Fbxo2, Six1, Netrin1 and its receptors
DCC and Unc5C were up-regulated
as were genes associated with neural
crest cells, including Ednrb and Ret.
Few genes associated with glial
differentiation (Fu et al., 2009) were
identified, and genes that inhibit oli-
godendrocyte or astrocyte differentia-
tion, e.g., Hes5 (Liu et al., 2006) and
Id4 (Marin-Husstege et al., 2006)
were induced.
Activation or silencing of lineage-
specific sets of genes during develop-
ment is controlled by transcription
factors as well as by epigenetic
regulators of chromatin structure.
Because ESC have a chromatin
configuration that is “poised” for line-
age differentiation (e.g., Boyer et al.,
2006), selective induction of
chromatin regulators associated with
other lineages, or removal of repres-
sive marks on neuronal promoters/
enhancers could drive neuronal differ-
entiation. We examined the expres-
sion of transcripts encoding proteins
involved in chromatin modification
including SWI/SNF, polycomb family
members, HDACs, etc., and found
minimal (< three-fold) changes. There
were three exceptions that are of
potential interest. The first is in Fork-
head box (Fox) gene expression. Foxa
proteins are considered “pioneering”
in that they open chromatin to allow
modifiers access to chromatin, Foxp
factors function as classic transcrip-
tion factors recruiting enzymes to reg-
ulate gene expression, while Foxo
proteins appear to do both (Lalman-
singh et al., 2012). Following Neurog1
expression, Foxa2 was increased 21.2-
and 13.7-fold at 48 and 72 hr, and
Foxp2 was increased 62.4- and 53.8-
fold at similar time points, suggesting
a role in neuronal lineage differentia-
tion. Second, Phc2, a polycomb group
member expressed in germinal zones
of the nervous system (Kim et al.,
2005), was induced 7.1-, 8.9-, and 8.3-
fold. Finally, the histone methyltrans-
ferase, Suv39h1 was down-regulated
35.7- and 17.6-fold at 48 and 72 hr.
Suv39h proteins have been shown to
oppose Ring1 to coordinate early line-
age decisions in the blastocyst (Alder
et al., 2010), and to interact with
Smads to coordinate BMP-induced
gene repression and lineage differen-
tiation (Frontelo et al., 2004). Some-
what surprisingly, given a recent
study demonstrating that Ezh2 is
required to inhibit transcription of non-
muscle lineage genes in satellite cells
(Juan et al., 2011), we did not observe
alterations in either the ubiquitous
Ezh1 or in Ezh2 associated with prolif-
erating tissues (Margueron et al.,
2008). Future interrogation using ChIP
and knock-down will explore these pos-
sibilities more directly.
Microarray analysis also identified
a complex pattern of expression of
genes involved in cell cycle control. At
24 and 48 hr, cluster analysis did not
identify any significant clusters con-
taining cell cycle related genes, but by
72 hr of transgene induction, three
clusters identified down-regulated
genes involved in cell cycle. Cluster 3
(Enrichment Score¼7, P5.0  109,
Benjamini-Hochbert corrected) con-
tained genes involved in cell cycle pro-
gression, Cluster 4 (Enrichment
Fig. 8. Quantification of dorsal–ventral phenotypes with Sonic hedgehog (Shh) and Noggin
(Nog) treatment. There was a dose-dependent decrease in the percentage of Pax7þcells and an
increase in the percentage of Nkx6.1-positive cells following Nog and Shh treatment. Differences
observed between all treatment groups were statistically significant (P0.05, analysis of var-
iance, followed by pairwise Student’s t-test). n¼1,000 cells from 10 random fields from two repli-
cate cultures. #Shh¼2.5 nM, "Shh¼25 nM, #Nog¼2 nM, "Nog¼5 nM.
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Score¼5.5, P3.1  109, corrected)
identified genes involved in chromo-
some organization, sister chromatid,
and centromere structure, while Clus-
ter 7 (Enrichment Score¼4.9, P2.3
 106, corrected) identified genes
involved in chromosome organization
(Supp. Table S2).
Because the ESC population is rela-
tively homogeneous (compared with
brain tissue) it is possible to examine
the sequential expression/repression
Fig. 9. Neuronal differentiation by means of forced Neurog1 expression is affected by fibroblast growth factor (Fgf) signaling. A: Treatment
groups. N7 cells were plated in defined medium (time¼0 hr) and exposed to a 12 hr pulse of 5 nM SU5402. One group (preinduction) was treated
with SU5402 at the time of plating, after which the medium was exchanged for fresh medium supplemented with 1 mg/ml doxycycline (þDox) for
the remainder of the culture period. The second group (simultaneous) was plated in defined medium for 12 hr followed by addition of SU5402 and
Dox. At 24 hr, the medium was exchanged for fresh medium supplemented with Dox for the remainder of the culture period. The final group (post-
induction) was plated in defined medium for 12 hr followed by addition of Dox. At 24 hr, a 12-hr pulse of SU5402 was administered, and, at 36 hr,
the medium was exchanged for fresh medium supplemented with Dox for the remainder of the culture period. B: Oct4/Sox3/TuJ1 cell counts.
There was a decrease in the number of Sox3þ cells between the preinduction and simultaneous treatment groups that was not significant
(**P¼0.058), while the decrease in the number of Sox3þ cells in the post-dox group was slight but significant compared with the other treatment
groups. There was a striking increase in TuJ1 expression with delayed SU5402 treatment and a corresponding decrease in the number of Oct4þ
cells, while the number of Sox3þ cells observed dropped only slightly with delayed treatment. Untreated controls demonstrated markedly
increased neuronal differentiation, a concomitant reduction in neuronal precursor cells, with very few cells expressing Oct4. At least 1,000 cells
from 10 randomly selected fields in two replicate dishes were scored for Oct4, Sox3, and TuJ1, and analyzed by pairwise Student’s t-test. C:
Oct4/Sox3/TuJ1 immunohistochemistry. The cell counts described above were obtained from cell cultures that were fixed after 72 hr and co-
stained with TuJ1 and Oct4 antibodies (left panels) or TuJ1 and Sox3 antibodies (right panels). Nuclei are labeled with Hoechst 33258. Blocking
FGF signaling resulted in fewer neurons (TuJ1þ) in a manner depending on the timing of treatment. Control cells receiving no SU5402 show robust
neuronal differentiation.
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TABLE 2. Microarray Expression Analysisa
Gene UniGene # 24h 48h 72h
Pluripotency Factors
Eed Mm.380914  3.6 4
Eras Mm.250895 4.9 34 66
Fbxo15 Mm.28369  14
Foxd3 Mm.4758  12
Klf2 Mm.26938  28 41
Klf4 Mm.4325 8.4 16 23
Nanog Mm.440503 4.7 23 33
Pou5f1 Mm.17031 4.8 27 38
Sox2 Mm.65396  2.7
Tert Mm.10109  3.5
Zic3 Mm.255890 2.2 5.5 10
Neural Differentiation
Ascl1 Mm.136217 
Brn2 Mm.129387  7.2
Dclk1 Mm.393242  41 120
Dcx Mm.12871 8.2 194 359
Ebf2 Mm.319947 95.7 159 96.3
Ebf3 Mm.258708 47.7 186 282
Ednrb Mm.229532  195
Elavl3 Mm.390167  30.9 35
Elavl4 Mm.3970  75 144
Fabp7 Mm.3644 49.4 201 444
Gfap Mm.1239 
Isl1 Mm.42242 10.1 89.3 197
Lhx2 Mm.142856 54.8 145 192
Myt1 Mm.458718  24 66.2
Ncam1 Mm.4974  6.8
Nefh Mm.298283 2.3 2.4 2.6
Nefl Mm.1956 2.7 4.2 23.4
Nefm Mm.390700  258
Neurod1 Mm.4636 9.7 11.5 10.2
Neurod4 Mm.10695 33 206 128
Neurog1 Mm.266665 74.4 74 42.7
Neurog2 Mm.42017  4.4 3.8
Nhlh1 Mm.2474 27.4 102 105
Nhlh2 Mm.137286  110 204
Nr2f1 Mm.439653  90.1 198
Nr2f2 Mm.158143  74.9 106
Nrxn1 Mm.480021  76.3 228
Olig1 Mm.39300  
Olig2 Mm.37289  
Olig3 Mm.156946 4.5 19.6
Pax3 Mm.1371 20.2 177 98.3
Pax6 Mm.33870  10.8 23.1
Prom1 Mm.6250  10 0
Rein Mm.425236  40.8 43.3
Rest Mm.28840 4.5 6.4 16
Ret Mm.57199  96.8 251
Runxlt1 Mm.4909  5.6 19.3
Soxl1 Mm.41702 4.2 34.7 43.1
Sox3 Mm.35784 9.9 15.7 11.9
Sox4 Mm.240627 6.1 13.2 18
Tubb3 Mm.40068  7.7 8.7
Zeb1 Mm.3929  6.4 6.5
Zfp238 Mm.480309 6.6 11.1 7.8
Zic1 Mm.335350 53.4 40.7 31
Neural Patterning
Eya1 Mm.250185  7 11.6
Foxa2 Mm.938  21.2 13.7
Foxd1 Mm.347441  11.1 23.9
Foxg1 Mm.390496  13
242 VELKEY AND O’SHEA
TABLE 2. Continued
Gene UniGene # 24h 48h 72h
Foxp2 Mm.332919  46.7 438
Hoxa1 Mm.197 24.3
Hoxa2 Mm.131  18 24.4
Hoxa4 Mm.439647  21.9
Hoxb1 Mm.890 10.7 16.5
Hoxb2 Mm.281153 33.5 92.7 79.4
Hoxb4 Mm.3546 22.6 43.3 45.6
Hoxd9 Mm.26544  10.6
Irx1 Mm.316056  4.2 6.5
Hoxb2 Mm.281153 33.5 92.7 79.4
Hoxb4 Mm.3546 22.6 43.3 45.6
Hoxd9 Mm.26544  10.6
Irx1 Mm.316056  4.2 6.5
Irx3 Mm.238044 8.5 39.9 42.6
Isl1 Mm.42242 10.1 89.3 197
Neural Patterning
Lhx2 Mm.142856 54.8 145 192
Onecut1 Mm.303355 18.3 13 27.3
0necut2 Mm.234723 8 121 185
Six1 Mm.4645 5.2 15.5
Cell Surface
Cdh1 Mm.35605 8.9 11
Cdh2 Mm.257437 18.3 31.8
Dab1 Mm.289682 2.9 5.4
Dcc Mm.167882 61.5 114
Efna1 Mm.15675 
Efna5 Mm.7978 5.2 6.6
Efnb1 Mm.3374 12.7 2.9 
Efnb2 Mm.209813 8.3 9.6
Epha1 Mm.133330 34
Epha2 Mm.2581 6 6
Epha3 Mm.1977 4.3 
Epha4 Mm.400747 2.2 2.2 2
Epha5 Mm.137991 18 43.7
Ephb1 Mm.22897 
Ephb2 Mm.250981 2.6 3.7
Esrrg Mm.89989 98
Itga1 Mm.317280 4.8 
Itga5 Mm.16234 3.1
Itga6 Mm.225096 2.5 4.6
Netrin1 Mm.39095 3.2 14.2 
Ntrk1 Mm.80682 11.4 
Ntrk3 Mm.421361 6.2 22
Pcdh8 Mm.390715 10.5 155 108
Plxna1 Mm.3789 3 2.3
Plxna2 Mm.2251 7.1 64.1 58.1
Plxnb1 Mm.53862 2.8 2.5
Plxnc1 Mm.256712 10 11.6
Plxnd1 Mm.3085 5.9 6.9
Robo1 Mm.310772 4.6 6.3
Sema3c Mm.5071 12.8
Sema3d Mm.89313 13.8




Sema5a Mm.260374 3.5 4.3 4
Sema6a Mm.40909 4.7
Sema6d Mm.330536 11.3 37.7 44.9
Slit1 Mm.40322 8.6 
Slit2 Mm.289739 3.5 8.1
Synpr Mm.37515 47.5 145
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TABLE 2. Continued
Gene UniGene # 24h 48h 72h
Unc5c Mm.24430 12.2 31.8
Signaling
Bmp1 Mm.27757 2.7 5.8 4.7
Bmp4 Mm.6813 6.2 8.1
Dil1 Mm.4875 15.8 8.3 4.2
DII3 Mm.12896 19.9 20.5 5.5
DII4 Mm.143719 58.2 56 18.8
Dner Mm.292560 12 23
Fgf4 Mm.4956 4.7 48 8.1
Fgf5 Mm.5505 
Fgfl2 Mm.7996 20.9 30.6
Fgfl3 Mm.7995 5.2
Fgfl5 Mm.3904 3.6 
Fgfl7 Mm.12814 13 92 56
Frzb Mm.427436 46.3 35.9
Gli1 Mm.391450 15
Gli2 Mm.273292 2.9 3.8
Gmnn Mm.12239 2.7 3
Hes5 Mm.137268 21 385 203
Hes6 Mm.280029 17.9 7.5 2.6
Hhat Mm.145857 3.6 5.2 4.7
Id2 Mm.34871 2.9 
Id3 Mm.110 11 
Id4 Mm.458006 5.8 20.7 14.8
Igflr Mm.275742 3.1 
Igf2bp3 Mm.281018 3.4 2.3
Igfbp2 Mm.141936 2.6 4.9
Igfbp4 Mm.233799 25.4 13.5
Igfbp5 Mm.405761 18.1 25.3
Igfbp7 Mm.233470 3.2 4.9
Signaling
Igfbpl1 Mm.3919 9.4 67.1 58
Inhbb Mm.3092 12 44 131
Jag1 Mm.22398  6.2 3.8
Nik Mm.9001   2.1
Nodal Mm.57195 2.2 14 22
Notch1 Mm.290610 2.8
Notch2 Mm.254017 3 2.7
Notch4 Mm.173813  4
Ntrk1 Mm.80682  11.4
Ntrk2 Mm.130054  
Ntrk3 Mm.33496  6.2 22
Sfrp2 Mm.19155   12.4
Smad1 Mm.223717  4.2
Smad2 Mm.391091  2.1
Smad3 Mm.7320 2.8 2.8
Smad4 Mm.100399  
Smad7 Mm.34407 5.1 8.7 6.6
Socs2 Mm.4132 2.1 4.4 17
Socs6 Mm.91920  4.7 5.2
Stat1 Mm.277406 3.9 
Stat3 Mm.249934 2 2
Cell Cycle
G1/S checkpoint
Cdkn1a Mm.195663  5 3
Suv39h1 Mm.9244 2.9 35.7 17.6
Trp53 Mm.222  3.3 5.5
G1/S
Btg2 Mm.392646 3.6 4
Cables1 Mm.40717 2.3 2.7
Ccnd1 Mm.16110 2.2 6.1 6.9
Ccne1 Mm.16110  6.1 6.9
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of transcripts involved in cycle regula-
tion (Table 2). Positive regulators of
cell cycle including: Birc5, Id3, Skp2
were down-regulated, and negative
regulators: Btg2, Ccng2, Ebf2,3,
Gadd45g, Gspt1, Hipk2, Prmt2 were
up-regulated with transgene expres-
sion. However, other positive regula-
tors were stimulated, including:
Ccnd1, Ccnd2, Cdc25b, Cyr61, Gpc1,
Hmga2, Tead2. Others were strongly
changed initially by transgene induc-
tion but then were reduced by 48 or
72 hr, including: Cdc25b, Gadd45g,
and Id3. Of interest, the tumor sup-
pressor Trp53/p53 was down-regu-
lated significantly both at 48 and 72
hr of induction. P53 plays major roles
in apoptosis, cell cycle arrest, and by
means of its downstream targets
Gadd45g and p21 (Cdkn1a) which is
up-regulated at all time points, which
functions as a G1 regulator to produce
growth arrest.
We also compared gene expression
in Neurog1-expressing cells at 24 vs.
48, 48 vs. 72 and 24 vs. 72 hr time
points. Overall, microarray analysis
of changes in gene expression
between 24 and 48 hr identified sets
of genes expressed in neural stem
cells, neural crest and placodes. Com-
paring 24 and 72 hr patterns, increas-
ing numbers of mature markers
including channel genes, neurotrans-
mitter/receptor genes were identified,
consistent with our previous observa-
tions that they exhibit mature axon
potentials (Reyes et al., 2008).
TABLE 2. Continued
Gene UniGene # 24h 48h 72h
Cdca5 Mm.23526  3.1 3.7
Cdkn1a Mm.195663  5 3
Ccnd2 Mm.333406  3 6
Gspt1 Mm.325827  2.1 2.1
S
Brca2 Mm.236256 2.8 3.4
Cdt1 Mm.21873  2.8 3.7
Pola1 Mm.1923  2.5 3
Skp2 Mm.35584 2.5 2.2 2.3
G2/M Checkpoint
Cdk1 Mm.281367  
Cdt1 Mm.21873  2.8 3.7
Pola1 Mm.1923 2.5 3
Tipin Mm.196219 2.6 3.4
G2/M
Birc5 Mm.8552  3.4 5
Ccnb2 Mm.22592   3.1
Cdc25b Mm.38444 4.6 
Cdkn1a Mm.195663  5 3
Gadd45g Mm.281298 9.6 
Gpc1 Mm.297976 3.6 3.9
Hmga2 Mm.157190  3
M
Aurka Mm.249363  2.9 3.7
Birc5 Mm.8552  3.4 5
Bub1b Mm.29133  4.2 4.8
Ccdc99 Mm.194368  2.4 3
Ccnb1 Mm.260114 3.3 4.5
Ccnb2 Mm.22592  3.1
Ccng2 Mm.3527 3.7 6.2 5.6
Cdc20 Mm.289747  3 4.2
Cep55 Mm.9916  6.1 6.3
Ercc61 Mm.31911  4.9 6.6
F630043A04Rik Mm.30173  2.3 3.9
Fbxo5 Mm.197520  2.9 4
Hells Mm.57223 3.5 4
Incenp Mm.29755 2.7 3.1
Ndc80 Mm.225956  2.6 3.3
Nek2 Mm.33773  2.8 4
Nup43 Mm.299887  3.3 3.7
Plk1 Mm.16525 2 2.5 3.5
Rcc2 Mm.253  4.4 5.1
Spc24 Mm.295642  3 3.3
Tipin Mm.196219 2.6 3.4
aFold changes in gene expression following 24 hr, 48 hr, and 72 hr of transgene induction.
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To validate the microarray data, we
chose to examine Notch-Delta path-
way members, as they have previ-
ously been suggested to be targets of
Neurog1 (Ma et al., 1997). As early as
12 hr after doxycycline treatment,
expression of Notch pathway mem-
bers was strikingly up-regulated,
remaining high during the 72 hr cul-
ture period. Over time in control cul-
tures there was a gradual increase in
expression of pathway members,
Notch1, Jag1, and Hes1 as neuronal
differentiation increased (Fig. 10).
Consistent with these observations,
at 24 hr, array analysis identified
Notch2 (three-fold), Hes5 (21) and
Hes6 (17.9) as up-regulated (Table 2).
By 48 hr, many pathway members
including Notch1 (2.8), Notch2 (2.7),
Notch4 (-4), Jag1 (6.2), Hes5 (384),
Hes6 (7.5), Dner (12) were identified.
At 72 h, Jag1 (3.8) and Hes5 (203.2),
Hes6 (2.6), and Dner (23) were up-
regulated.
Microarray data have been





Neurog1 in ESC Provides a
Novel Model of Neurogenesis
ESC provide a powerful model system
to study the mechanisms of cell fate
specification and lineage segregation
at a stage in early development not
readily accessible for manipulation.
Studies of directed ESC differentiation
typically rely on differentiation in
embryoid bodies and/or exposure to
stromal cell derived factors or to non-
specific morphogens such as RA. While
these approaches can produce popula-
tions enriched with neurons (e.g., Zeng
et al., 2011), undefined factors and en-
dogenous cytokines present in EBs,
media containing serum, or stromal
cell co-culture, complicate efforts to
understand the role of specific signal-
ing pathways in lineage segregation.
Differentiation of ESC in monolayer
cultures in defined media minimizes
these effects (e.g., Ying et al., 2003b)
and, if combined with forced expres-
sion of a lineage restricted gene,
presents a unique opportunity to tease
out the interactions of particular genes
and growth factors in early develop-
ment. An additional advantage of the
inducible gene expression paradigm is
the ability to maintain transgene
expression following implantation
(Reyes et al., 2008). Here, we demon-
strate that expression of Neurog1 in
ESC is sufficient to induce neuronal
differentiation even in conditions that
normally maintain pluripotency (ad-
herent culture at high density with se-
rum and LIF), in defined media where
the presence of morphogens can be
more precisely controlled.




Consistent with the pattern of
Neurog1 expression in defined
domains of both the CNS and PNS
(Ma et al., 1996; Sommer et al., 1996;
Murray et al., 2000; Kim et al., 2011;
Takano-Maruyama et al., 2012),
expression of Neurog1 in ESC is suffi-
cient to generate neuronal precursors
and mature cell types representative
of these expression domains (Figs. 4,
5). In fact, this paradigm may repre-
sent a reliable method to obtain
sensory neurons, which have been
difficult to generate from embryonic
stem cells (Sasai, 2005). We observed a
significant number of neurons that
expressed Brn3a, a POU homeodo-
main transcription factor associated
with sensory lineages in both the CNS
and PNS. In the CNS, Brn3aþ sensory
lineages arise throughout the ante-
rior–posterior extent of the dorsal
alar plate in the neural tube. In the
posterior spinal cord, the alar plate
generates Brn3aþ dorsal interneur-
ons, of which the dI2 commissural
lineage is specifically Neurog1-
dependent (Gowan et al., 2001),
whereas rostral domains of Brn3a and
Isl1 expression are present in the tec-
tum and tegmentum of the midbrain
(Fedstova and Turner, 2001). A 4 kb
enhancer has been shown to drive
reporter gene expression to the mid-
brain, hindbrain and spinal cord
(Nakada et al., 2004), while a second
0.8 kb enhancer drives expression to
cells fated to become interneurons in
the ventral spinal cord (Quinones
et al., 2010). The presence of periph-
erinþ cells in our cultures presents the
intriguing possibility of having gener-
ated motor neurons which express this
marker (Escurat, et al., 1990). How-
ever, these cells almost invariably
co-expressed Brn3a, which has not
been reported in motor neurons, but is
more suggestive of PNS lineages.
Regarding glial differentiation, we did
not observe any up-regulation in glial
markers in either our microarray
analyses (Table 2) or by RT-PCR or
immunohistochemistry (not shown).
Moreover, our previous work similarily
failed to detect GFAPþ cells in vivo or
in vitro (Reyes et al., 2008), consistent
with observations that Neurog1 pro-
motes neurogenesis while inhibiting
gliogenesis (Sun et al., 2001) and
detailed fate mapping studies in which
Neurog1 was found to be exclusively
associated with neuronal lineages
(Kim et al., 2011).
In the PNS, Neurog1 has been
shown to be instructive for sensory
neurogenesis (Perez et al., 1999; Lo
et al., 2002) and required for the gen-
eration of proximal cranial sensory
Fig. 10. Induced N7 cells express Notch-Delta pathway members in a dose-dependent man-
ner. Cells cultured in defined neural medium with 0, 0.5, 1, or 2 mg/ml doxycycline up-regulate
the Notch1 receptor and its ligand Jagged1, as well as the downstream target of Notch activa-
tion, Hes1. Up-regulation of genes associated with Notch-Delta signaling is correlated with the
expression of Neurog1, providing further evidence of an interaction between Neurog1 and the
Notch-Delta signaling pathway, as observed in microarray analysis.
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ganglia and TrkA neurons of dorsal
root ganglia (Ma et al., 1997),
whereas Atoh1 is associated with de-
velopment of adrenergic autonomic
ganglia (Guillemot et al., 1993).
Correspondingly, we failed to detect
tyrosine hydroxylase, a marker of
adrenergic neurons in any of our
cultures (not shown) but instead
found many peripherinþ neurons
that invariably co-expressed Brn3a
(Fig. 5E,F), a phenotype representa-
tive of both cranial and dorsal root
sensory ganglia (Gowan et al., 2001).
A possible caveat to this interpreta-
tion is that Brn3a (Nadal-Nicolas
et al., 2009) and peripherin (Tajika
et al., 2004) are also co-expressed in
retinal ganglion cells, but other
markers of retinal ganglion cells
such as Chx10, Dlx1, Dlx2, and
Brn3b (de Melo, et al., 2003) were not
significantly up-regulated in our
microarray analysis, making this
phenotype less likely.
Derivation of neural crest from
ESC typically is a multistep process
that requires sequential exposure to
multiple growth and differentiation
factors (Mizuseki et al., 2003; Aihara
et al., 2010; Kawaguchi et al., 2010).
Our findings suggest that Neurog1
expression can direct ESC toward
Retþ, Ednrbþ neural crest fates, and
induces expression of Sox4 and Sox11
required in early sympathetic ganglia
(Potzer et al., 2010), in the absence of
exogenous instructive signals. How-
ever, our cultures contained a mixture
of CNS and PNS types, and it remains
to be determined what factors in addi-
tion to Neurog1 expression mediate
the choice between these lineages.
ESC Expressing Neurog1 Can
be Patterned Along the
Anterior–Posterior and
Dorsal–Ventral Axes and
Influenced by Fgf Signaling
Expression of Neurog1 prompted early
expression of forebrain (Otx2, Hoxa1)
as well as midbrain (Engrailed1, not
shown) markers, strong induction of
Hoxb2 but not of more posterior
markers including Hoxc6. However,
treatment of these cultures with RA
promoted expression of Hoxc6 and
down-regulation of anterior markers.
These data suggest that these cells
possess an intrinsic anterior character
that can be posteriorized by RA- medi-
ated signals (Irioka et al., 2005).
Because these cultures lack other cell
types, these results clearly demon-
strate that Neurog1-expressing neuro-
nal precursors possess an anterior
character in the absence of confound-
ing “mesendodermal” signals.
Based on previous gain-of-function
studies, we expected that Neurog1
expression in ESC would produce spe-
cific subtypes of neurons independent
of any endogenous patterning mole-
cules. However, we were surprised to
find that induced cells were quite
responsive to dorsal–ventral (DV)
patterning molecules (Wilson and
Maden, 2005) such that more ventral
phenotypes were observed in cultures
treated with Shh, and this effect could
be augmented by addition of Noggin
protein. RA treatment alone also
produced ventral phenotypes. In addi-
tion, noggin treatment accelerated
and BMP treatment suppressed neu-
rogenesis in our cultures. Together,
these data indicate that ESC forced to
express Neurog1 progress through a
stage where they remain receptive to
patterning cues.
Recent evidence indicates that
FGFs may have an independent and
indispensable role in the induction of
neural fate in vivo (Streit et al., 2000;
Wilson et al., 2000; Lanner and
Rossant, 2010) and in the neuronal
differentiation of ESC (Ying et al.,
2003a). Fgf signaling can maintain
self-renewal of ESC (Sterneckert
et al., 2010; Staviridis et al., 2010),
and is required for cell cycle exit and
the transition to lineage differentia-
tion (Kunath et al., 2007). Other
studies have demonstrated that Fgf
signaling is essential for the progres-
sion of ESC to an epiblast state
(Stavridis et al., 2010); preventing de-
differentiation to a more primitive
ICM-like state (Greber et al., 2010)
and inhibiting neural differentiation
(Greber et al., 2010; Jaeger et al.,
2011). Our data suggest that expres-
sion of Neurog1 in ESC is sufficient to
generate Sox3þ progenitors inde-
pendent of Fgf signaling (Fig. 9B).
However, the reduction in the per-
centage of neurons in the preinduc-
tion and simultaneous induction
treatment groups, and striking
increase in the number of Oct4þ and
Sox3þ cells in the earlier treatment
groups, suggests that the initial speci-
fication of Sox3þ precursors in the
context of Neurog1 expression does
not require Fgf signaling. However,
there is a window where inhibition
of Fgf signaling interferes with the
ability of these precursors to differ-
entiate into mature neurons. It has
been suggested that inhibition of
Fgf signaling can revert epiblast
stem cells to an Oct4þ ESC state
(Greber et al., 2010). However, we
failed to detect up-regulation of epi-
blast markers such as Fgf5, but we
did see markers of neural ectoderm
such as Pax 6 (Table 2), suggesting
that neuronal differentiation by
means of Neurog1 expression likely
bypasses an epiblast state. Nonethe-
less, the Oct4 pathway appears to
be initially intact in these cells and
abrogation of Fgf signaling re-
engages ESC programs that inhibit
neuronal differentiation.





analyses indicated that all of the cells
in our cultures express Neurog1 (Fig.
2), not all matured into neurons after
3 or even 5 days in culture, similar to
previous observations in embryonal
carcinoma (EC) (Farah et al., 2000;
Kim et al., 2004) and ESC (Kanda
et al., 2004). Although primitive neu-
ral stem cells appear relatively insen-
sitive to Notch signaling, definitive
neural stem cells may be maintained
in an undifferentiated state by activa-
tion of the Notch pathway (Tropepe
et al., 2001), like neuronal precursors,
whose differentiation into mature
neurons can be held in check by the
Notch-Delta pathway (reviewed in
Louvi and Artavanis-Tsakonas, 2006).
We observed that induction of Neu-
rog1 results in transient expression of
the Notch ligand, Jag1 (Fig. 10; Table
2), and of Dll1,3,4 (Table 2), as well as
up-regulation of Hes1, Hes5, and
Hes6, repressor-type bHLH factors
that are downstream targets of the
Notch signaling pathway. The Notch
target gene Hes5, required for NSC
maintenance (Basak and Taylor,
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2007; Hatakeyama et al., 2004), was
strongly induced by Neurog1. In fact,
the up-regulation of these repressor-
type bHLHs is more likely the effect
of Jag1 expression in neighboring
cells than a direct effect of Neurog1
expression. Thus, ESC expressing
Neurog1 may progress through a
Notch-sensitive stage in which cells
at the edge of rosettes escape inhibi-
tion to differentiate into neurons, and




Because Neurog1 is expressed early
in the neurogenic cascade at the time
of lineage commitment/determination
(Blader et al., 1997), we used microar-
ray analysis to identify transcripts
expressed down-stream of Neurog1.
Many of the genes strongly induced
by Neurog1 are expressed in the strat-
ifying neural ectoderm at the time of
cell cycle exit (Fu et al., 2009); cou-
pling Neurogenin1 expression with
cell cycle exit and neuronal differen-
tiation (Kim et al., 2011). Other candi-
date transcription factors such as
Sox4 and Sox11, which are known to
play a role in the downstream effects
of proneural bHLH factors, were
strongly induced, while genes associ-
ated with ESC maintenance, and
inhibitors of neuronal differentiation
were down-regulated. In addition,
genes associated with astrocyte and
oligodendrocyte differentiation were
not identified or were down-
regulated.
Genes associated with neuronal cell
migration were strongly induced by
Neurogenin1, including the microtu-
bule associated protein doublecortin
(Dcx), Cdn2, reelin, CoupTF factors
(Nr2f1, Nr2f2; Tripodi et al., 2004), as
well as EphA5 previously identified
as down-regulated in Neuro-
g2:Neurog1 double mutant mice (Mat-
tar et al., 2004). There was also a
striking switch in expression of genes
associated with an epithelial morphol-
ogy including junctional proteins, as
well as E-Cadherin (by ESC) to N-
Cadherin by differentiating neurons.
These data suggest that Neurog1
expression activates a program of
neurogenesis that includes cell sur-
face changes, induction of genes
involved in cell migrations, transcrip-
tion factors and cell cycle modulators.
In a screen of Ngnr1 and NeuroD
targets in Xenopus, Seo et al. (2007)
identified similar sets of target genes:
47% of the genes induced by Ngnr1
over-expression in Xenopus were
identified in our analysis, while 43%
of the genes induced by NeuroD were
present in our screen. Somewhat sur-
prisingly, all of the seven core regula-
tory factors suggested to promote
Neurogenin-mediated neurogenesis:
Ebf2,3, Hes6, Myt1, Nhlh1, Neurod1,
Neurod4, and Runx1t1 (Pang et al.,
2011) were significantly increased in
our cells. An in silico analysis to iden-
tify targets of Neurog2 (dorsal telen-
cephalon) vs. Ascl1 (ventral
telencephalon) (Gohlke et al., 2008)
identified only Dcx, Elavl4, Nrarp, in
common with our Neurog1 down-
stream targets; and one, Fzd5, was
down-regulated significantly in our
analysis. Of interest, constitutive
over-expression of NEUROG1 in a
cell line derived from human fetal tel-
encephalon identified 588 potential
target genes; 27.7% of them were
identified in this analysis at 72 hr.
These represent a very different pop-
ulation as telencephalon progenitor
cells expressed transcripts associated
with glial cells as well as with neu-
rons (Satoh et al., 2010). Similarly,
expression of transcripts in the hind-
brain neural ectoderm on E11.5—
when Purkinje progenitors are devel-
oping—in Neurog1/ embryos iden-
tified 31/117 transcripts also present
in our analysis. These data suggest
that ultimately, subtype specificity is
likely controlled by combinations of
bHLH proteins and region-restricted
transcription factors (particularly
homeodomain proteins), which in
combination with noncoding RNAs,
may regulate each other or stabilize a
neurogenic program.
Other candidates that may act in
concert with bHLH factors to restrict
lineage progression are chromatin
regulators. The ESC faces the unique
problem of maintaining both self-
renewal and pluripotency, which it
may solve with a unique bivalent
chromatin structure in which
enhancers of lineage-specific genes
are associated with specific methyla-
tion marks that repress lineage gene
expression “poised chromatin”, while
pluripotency genes maintain an
“active” chromatin through successive
rounds of division. These modifica-
tions are lost with differentiation
(Boyer et al., 2006), but many are re-
set with somatic cell reprogramming
(Creyghton et al., 2010). In fact, it has
been suggested that because many
lineage-specific transcription factors
belong to large families that recognize
a common binding sequence, e.g., the
E box, additional mechanisms, such
as chromatin modification, must exist
to limit the sites available for tran-
scription factor binding (Conerly
et al., 2011). Our microarray analysis
identifies several transcripts encoding
chromatin modifying factors as possi-
ble targets of Neurog1. These factors
may function to restrict binding of
non-neuronal lineage factors during
Neurog1 driven differentiation, and
may ultimately suggest methods for
direct reprogramming of adult cells to
neurons. Additional work will exam-
ine direct interactions and use shRNA
to probe their roles in the context of
Neurog1 expression.
Neurog1 Alters Cell Cycle
Progression
Although the proneural bHLH genes
Atoh1 (Math1), Asc1 (Mash1), Neu-
rog1/2 promote cell cycle exit and
expression of neuronal genes, the
mechanisms involved and target
genes are largely unknown. Recently
two large-scale analyses of gene
expression downstream of Ascl1 (Cas-
tro et al., 2011) and Atoh1 (Machold
et al., 2011) identified transcripts
involved in cell cycle exit and sequen-
tial phases of neural differentiation.
While it is not surprising that prolif-
erating granule cell precursors main-
tained Atoh1 and cell cycle genes, in
the current investigation we also
identified genes involved in positive
regulation of the cell cycle. Of the 95
cycle-related genes expressed by
Mash1þ rhombic lip precursors, 17
were also present in Neurog1 over-
expressing ESC, including: Aurka,
Birc5, Brca2, Bub1b, Ccnd1, Ccnd3,
Cdc20, Cdca2, Cdca5, Cdt1, E2f8,
Fbxo5, Gmnn, Hells, Jub, Nek2,
Trpt53/p53. Downstream of Ascl1
(Castro et al., 2011) only five were
genes were common to Neurog1 cells:
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Ccnd1, Ccd3, Cdkn1a/p21, Plk1,
Gadd45g.
Gadd45g, a strong inhibitor of cell
cycle progression (e.g., Mak and
Kultz, 2004) was strongly induced by
Neurog1 at 24 hr. Ebf3 was particu-
larly strongly up-regulated by Neu-
rog1 (48, 162, 182-fold at 24-hr
intervals); it has previously been
reported to be downstream of NeuroD
(Pozzoli et al., 2001). Ebf genes inhibit
cell cycle progression at G1/S, and
couple cycle exit and neural differen-
tiation (Garcia-Domingues, 2003);
over-expression decreases prolifera-
tion consistent with our observations.
Neuron-specific activators of the cell
cycle progression inhibitor Cdk5
(Cdk5r1/p35 and Cdk5r2/p39),
which are responsible for producing
the unique neuronal cell cycle, were
also increased. Other genes such as
E2f8, which is induced at G1/S and
acts as a repressor of cycle progres-
sion by means of p53 (Christensen
et al., 2005), were down-regulated in
Neurogenin1-expressing cells. Cdc20,
which has previously been associated
with increased neural plasticity (Con-
way et al., 2007), was also decreased
in N7 cells following transgene induc-
tion. This work demonstrates that the
neurogenic bHLH genes affect tran-
scripts involved in cell cycle progres-
sion, neural differentiation, migration
and apoptosis, and may reflect the
presence of a population of prolifera-
tive progenitors in the Neurog1-
expressing cells.
ESC, like the early epiblast, spend
most of their time in S phase and
have an attenuated G1 (Burdon et al.,
2002; White et al., 2005), possibly to
minimize exposure to differentiation
factors present in the local microen-
vironment (Orford and Scadden,
2008). Lengthening of G1, which
occurs with differentiation of the epi-
blast and ESC and is characteristic of
somatic cells, was also observed fol-
lowing expression of Neurogenin1.
Whether a cell exits cycle is deter-
mined at the G1 checkpoint, and exit
from cycle is required for many cell
fate decisions, consistent with the
presence of a population of prolifera-
tive precursors in these cultures.
The ability to induce expression of
Neurog1 in ESC constitutes a
straightforward and powerful model
system that provides insight into the
complex interplay of signaling mole-
cules and transcription factors that
shape the two-cell embryo into the
thousands of mature cell types pres-
ent in the adult PNS and CNS, and
increases our understanding and
eventual control of normal develop-
ment, birth defects and tumor forma-
tion. Ultimately, elucidation of the
molecular histogenesis of the nervous
system will also improve our under-
standing of the factors that promote
ectopic neurogenesis in several neuro-
degenerative conditions (Curtis et al.,
2003). In addition, primitive precur-
sors such as those that can be gener-
ated by the N7 cell line may be useful
for cell transplantation or as a
resource to identify down-stream tar-






of Inducible Neurog1 Cell
Lines
A Neurog1 insert from pCS2-ND3 (M.
McCormick) was ligated with an
EcoRI-NotI fragment from pI2R (Clon-
tech, Palo Alto, CA) containing an
IRES-DsRed2 cassette into the pLox
targeting vector to generate the tar-
geting construct, pLox-N1-I2R. To
generate targeted cell lines, 1.0  106
Ainv15 ESC (Kyba et al., 2002) were
plated in a 60-mm dish and co-trans-
fected 24 hr later with 1 mg each of
pLox-N1-I2R and pSalk-Cre (M.
Kyba) using Lipofectamine/Plus Rea-
gent (Invitrogen) in serum-free
DMEM. After 3 hr, the transfection
medium was replaced with complete
ES medium. The following day, the
cells were split to a 150-mm dish in
complete ES medium (see below) con-
taining 350 mg/ml G418 (Invitrogen).
After 10 days in selection, 12 colonies
remained, from which we were able to
establish 7 independent cell lines.
Three of these lines were selected for
additional analysis to confirm tar-
geted integration of the Neurog1
transgene at the tet-inducible locus,
stable expression of rtTA, doxycy-
cline-inducible expression of Neurog1,
and uniform neuronal differentiation
after 1 and 3 days of culture in
defined neural medium (described
below) with 1 mg/ml doxycycline
(Supp. Fig. S1). We observed no differ-
ences between the cell lines and we
therefore selected one of the lines, N7,
to carry out most subsequent
experiments.
Cell Culture and Neural
Differentiation
Ainv15 ESC were cultured on 0.1%
gelatin coated substrates in complete
ES medium (ESM) consisting of high-
glucose DMEM (Invitrogen, Carlsbad,
CA) supplemented with 10% ES-
tested fetal bovine serum (FBS)
(Atlanta Biologicals, Norcross, GA, or
Harlan Bioproducts, Indianapolis,
IN), 104 M b-mercaptoethanol
(Sigma, St. Louis, MO), 0.224 mg/ml
L-glutamine (Invitrogen), 1.33 mg/ml
HEPES (Invitrogen), and 1,000 units/
ml human recombinant LIF (Onco-
gene Research Products, San Diego,
CA). N7 cells were maintained in
ESM plus 350 mg/ml G418 (Invitro-
gen) and 1.5 mg/ml Puromycin
(Sigma). For neural differentiation,
cells were plated at 5.0  104 cells/
cm2 in gelatin-coated 6- or 12-well
plates in ESM or in defined medium
supplemented with 1 mg/ml doxycy-
cline (Sigma), and media changed ev-
ery day. Defined neural medium
consisted of 80% F-12/DMEM and
20% Neurobasal media with 10 ml/ml
MEM pyruvate, 8 ml/ml N2 supple-
ment, and 4 ml/ml RA-free B27 sup-
plement (all media components from
Invitrogen). Where indicated, media
were supplemented with 1 mM all-
trans-retinoic acid (Sigma). For long-
term culture, defined medium was
replaced after 3 days with doxycy-
cline-free serum replacement medium
(SRM5) consisting of high glucose
DMEM supplemented with 5% knock-
out serum replacer (Invitrogen), 104
M b-mercaptoethanol, 0.224 mg/ml L-
glutamine, and 1.33 mg/ml HEPES to
enhance cell survival. Where indi-
cated, recombinant growth factors (all
from R&D Systems, Minneapolis,
MN) were added to freshly prepared
media at the following concentrations:
25 nM (high) or 2.5 nM (low) mouse
Shh; 5 nM human BMP4; and 5 nM
(high) or 2 nM (low) Noggin-Fc chi-
mera. To examine the role of FGF sig-
naling, cultures were exposed at
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intervals to 5 nM SU5402 (Calbio-
chem) for 12 hr to block FGFR1
signaling.
Proliferation and Cell Cycle
Analysis
To analyze the effects of transgene
induction on proliferation, Ainv15
and N7 ESC were plated at 1  105
cells/well in 12-well plates in tripli-
cate (with four biological replicates)
in complete ES medium62 mg/ml dox-
ycycline. After 24, 48, and 72 hr, cells
were disaggregated using trypsin and
counted in a Coulter counter (Becton
Dickinson).
For cell cycle analysis, cells were
plated in triplicate at 2  105 in six-
well plates in complete ES medium62
mg/ml doxycycline. After 72 hr, cells
were fixed in cold absolute ethanol,
suspended in PBS and DNAse free
RNase A (Sigma) at a final concentra-
tion of 20 mg/ml. Samples were incu-
bated at 37

for 30 min and DNA
labeled with 0.1 mg/ml propidium
iodide (Sigma). Analysis was done in
a FACS Calibur using Cell Quest Pro
MAC 9.0 and cell cycle analysis done
with Mod Fit LT Mac 3.1 SP3.
RT-PCR
RNAs were extracted from lysates of
cells treated with TRIzol reagent
(Invitrogen), DNAsed, and quantified
by spectrophotometry. Control RNA
samples were obtained from N7 cells
cultured in ES medium and from
pooled samples of gestation day 9, 10,
and 11 mouse embryos. RNAs (1 mg
each) served as templates in reverse
transcription reactions with oligo-dT
primers, and 1/20 of the single-strand
cDNA products were used in each










C/1 min for 25–40
cycles. Specific information regarding
PCR primer sequences and reaction
conditions is provided in the on-line
supplementary material. The PCR
products (10 ml each) were electropho-
resed in 1.5% agarose gels in the pres-
ence of ethidium bromide, visualized
on a ultraviolet transilluminator and
digitally photographed using a Bio-
Rad Gel Documentation system. Pri-
mers and conditions are summarized
in Supplemental Table 3.
Immunohistochemistry
To examine cell type-specific and
positional markers, cells were fixed
in 2% paraformaldehyde for 15 min
at 25

C, then stored in PBS at 4

before processing for immunohisto-
chemistry (IHC). Briefly, cells were
permeabilized and nonspecific anti-
body binding blocked using host se-




were washed, then exposed to sec-
ondary antibody conjugated to Cy3
or FITC (Jackson ImmunoResearch
Laboratories) for 30 min at 25

C.
Nuclear staining for total cell num-
ber counts was achieved by incubat-
ing cells with 1 mM Hoechst 33285
(Sigma) for 2 min. Cells were
washed, then mounted using Pro-
long Gold (Molecular Probes/Invitro-
gen) and 25 mm coverslips. Cells
were examined, counted and photo-
micrographs imported into Photo-
shop using a Leica DMIRB inverted
microscope and Olympus digital
camera.
Primary antibodies included:
Sox3 (Mike Klymkowsky; 1:1,000)
expressed by in neural ectoderm and
neuronal precursors (Zhang et al.,
2003), Tuj1 (Covance MMS-435P;
1:250) which recognizes a neuron-spe-
cific class III b-tubulin expressed very
early in neuronal differentiation and
persisting in mature neurons (Moody
et al., 1987), peripherin (7C5, AbCam
ab4573, 1:1,000) which is expressed
in the PNS, Brn3a (Eric Turner,
1:1,000) expressed in sensory neu-
rons, tyrosine hydroxylase (Chemicon
AB5968, 1:1,000) expressed in adre-
nergic neurons, Oct4 (Santa Cruz
sc-8628, 1:100) expressed in undiffer-
entiated ES cells. Dorsal–ventral
markers included: Pax7 (Developmen-
tal Studies Hybridoma Bank superna-
tant, 1:20) labeling dorsal neural
progenitors, Nkx6.1 (N15, Santa Cruz
sc-15027, 1:100) expressed in ventral
progenitors, and Islet 1 which recog-
nizes Islet 1 and Islet 2 (Developmen-
tal Studies Hybridoma Bank, 39.4D5,
1:100) labeling ventral motor neurons
and dorsal root (sensory) ganglia, or
Dbx2 expressed in the middle zone of
the neural tube (Agalliu and Schie-
ren, 2009).
For quantitative analysis of the cell
types present, cell counts were per-
formed on 10 microscopic fields at
20 from at least two replicate cul-
tures, counting at least 1,000 cells per
replicate. For each field, the number
of a given cell type was divided by the
total number of cells present as deter-
mined by Hoechst nuclear staining to
calculate a percentage for each field
which was then summed to obtain a
mean percentage for each replicate.
The data presented are the overall
mean6SEM across all replicates.
Data were analyzed using ANOVA,
Students t-, or Chi-square test where
appropriate (with Bonferroni correc-
tion as necessary for multiple
comparisons); a P value of0.05 was
considered significant.
Microarray Analysis
RNAs were extracted as described
above from triplicate samples (cells dif-
ferentiated in three independent
experiments) of control N7 cells (-Dox)
at 24-hr culture intervals and N7 cells
exposed to doxycycline for 24, 48, and
72 hr. RNA was hybridized to Affyme-
trix Mouse 430 2.0 arrays (Santa
Clara, CA, http://www.affymetrix.com)
by the NIH NINDS arraying core at
TGen (http://www.tgen.org). The sig-
nal intensity of each array was nor-
malized to a mean of 150 by robust
multiarray averaging (RMA), then
GeneSpring (Agilent) software was
used to select genes withtwo-fold
change between groups. At each time
point, N7 cells (Dox) were used as
the reference for comparison with
þDox samples. Welch t-tests were
then carried out to identify significant
differences between controls and Neu-
rogenin1-expressing cells. Gene
expression was also compared in þDox
(and Dox control) samples at sequen-
tial time points (e.g., 24 vs. 48 hr, 48
vs. 72 hr, and 24 vs. 72 hr of transgene
induction). Benjamini-Hochbert false
discovery corrections were performed
on each comparison to reduce the num-
ber of false-positive results. Finally,
Gene Ontology, Functional Annotation
Clustering, and KEGG pathway analy-
ses were carried out using DAVID V
6.7 (Huang et al., 2009).
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